User menu

Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide.

Bibliographic reference Borbath, Ivan ; Leclercq, Isabelle ; Abarca-Quinones, Jorge ; Desaeger, Christine ; Lebrun, Valérie ; et. al. Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide.. In: Cancer science, Vol. 98, no. 12, p. 1831-9 (2007)
Permanent URL http://hdl.handle.net/2078.1/11130
  1. Parkin D. Maxwell, Bray Freddie, Ferlay Jacques, Pisani Paola, Estimating the world cancer burden: Globocan 2000, 10.1002/ijc.1440
  2. El-Serag Hashem B., Mason Andrew C., Rising Incidence of Hepatocellular Carcinoma in the United States, 10.1056/nejm199903113401001
  3. Williams GM, Toxicol Pathol, 17, 663 (1989)
  4. Altmann H.W., Hepatic Neoformations, 10.1016/s0344-0338(11)80394-8
  5. Goldsworthy TL, Crit Rev Toxicol, 17, 61 (1986)
  6. SOLT DENNIS, FARBER EMMANUEL, New principle for the analysis of chemical carcinogenesis, 10.1038/263701a0
  7. Becker RA, Cancer Res, 45, 2076 (1985)
  8. Lee Ju-Seog, Chu In-Sun, Mikaelyan Arsen, Calvisi Diego F, Heo Jeonghoon, Reddy Janardan K, Thorgeirsson Snorri S, Application of comparative functional genomics to identify best-fit mouse models to study human cancer, 10.1038/ng1481
  9. Dragan Y.P., Hully J., Crow R., Mass M., Pitot H.C., Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis, 10.1093/carcin/15.9.1939
  10. Susini C, Buscail L, Rationale for the use of somatostatin analogs as antitumor agents, 10.1093/annonc/mdl105
  11. Reubi Jean, Waser Beatrice, Schaer Jean-Claude, Laissue Jean A., Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands, 10.1007/s002590100541
  12. Reynaert H, Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma, 10.1136/gut.2003.036053
  13. Reubi JC, Gut, 45, 766 (1999)
  14. Bläker Michael, Schmitz Michael, Gocht Andreas, Burghardt Sylvia, Schulz Martina, Bröring Dieter C., Pace Andrea, Greten Heiner, de Weerth Andreas, Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas, 10.1016/j.jhep.2004.03.018
  15. Reynaert Hendrik, Vaeyens Freya, Qin Hong, Hellemans Karine, Chatterjee Nirjhar, Winand Dominique, Quartier Erik, Schuit Frans, Urbain Daniel, Kumar Ujendra, Patel Yogesh C., Geerts Albert, Somatostatin suppresses endothelin-1–induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1, 10.1053/gast.2001.27971
  16. Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I., Seino S., Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney., 10.1073/pnas.89.1.251
  17. Wang Jian, Li Jian-Sheng, Zhai Zhi-Ming, Xue Qiong, Jia Wei-Dong, Xu Ge-Liang, Xu Rong-Nan, Sun Hui-Chuan, Wang Lu, Yu Ji-Hai, Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts, 10.1007/s00432-003-0447-5
  18. Chen X, Chin Med J (Engl), 114, 1167 (2001)
  19. Liu HL, Acta Pharmacol Sin, 25, 1380 (2004)
  20. Notas George, Kolios George, Mastrodimou Niki, Kampa Marilena, Vasilaki Anna, Xidakis Costas, Castanas Elias, Thermos Kyriaki, Kouroumalis Elias, Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors, 10.1016/j.jhep.2004.01.016
  21. Raderer M, Int J Oncol, 16, 1197 (2000)
  22. Schindel David T, Grosfeld Jay L, Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide, 10.1016/s0022-3468(97)90385-7
  23. Barbare JC, J Clin Oncol, 23, 4036 (2005)
  24. Kouroumalis E, Gut, 42, 442 (1998)
  25. Yuen M, A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma, 10.1053/jhep.2002.35071
  26. Cebon J, Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide, 10.1038/sj.bjc.6603325
  27. Becker Gerhild, Allgaier Hans-Peter, Olschewski Manfred, Zähringer Andreas, Blum Hubert Erich, , Long-acting octreotide versus placebo for treatment of advanced HCC: A randomized controlled double-blind study, 10.1002/hep.21468
  28. Imai T, Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization, 10.1093/carcin/18.3.545
  29. Charland S., Somatostatin Inhibits Akt Phosphorylation and Cell Cycle Entry, But Not p42/p44 Mitogen-Activated Protein (MAP) Kinase Activation in Normal and Tumoral Pancreatic Acinar Cells, 10.1210/en.142.1.121
  30. de Luján Alvarez M, The in vivo apoptotic effect of interferon alfa-2b on rat preneoplastic liver involves Bax protein, 10.1053/jhep.2002.32099
  31. Xu Yi-Hua, Pitot Henry C., An improved stereologic method for three-dimensional estimation of particle size distribution from observations in two dimensions and its application, 10.1016/s0169-2607(02)00115-3
  32. Duan W Rachel, Garner Debra S, Williams Steven D, Funckes-Shippy Christie L, Spath Iwona S, Blomme Eric AG, Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts, 10.1002/path.1289
  33. Stärkel Peter, Bishop Kate, Horsmans Yves, Strain Alastair J., Expression and DNA-Binding Activity of Signal Transducer and Activator of Transcription 3 in Alcoholic Cirrhosis Compared to Normal Liver and Primary Biliary Cirrhosis in Humans, 10.1016/s0002-9440(10)63852-7
  34. Cammà Calogero, Giunta Marco, Andreone Pietro, Craxı̀ Antonio, Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach, 10.1016/s0168-8278(01)00005-8
  35. Ikeda Kenji, Arase Yasuji, Saitoh Satoshi, Kobayashi Masahiro, Suzuki Yoshiyuki, Suzuki Fumitaka, Tsubota Akihito, Chayama Kazuaki, Murashima Naoya, Kumada Hiromitsu, Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor—A prospective randomized study of hepatitis C virus–related liver cancer, 10.1053/jhep.2000.9409
  36. Kubo S., Nishiguchi S., Hirohashi K., Tanaka H., Shuto T., Kinoshita H., Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy, 10.1046/j.0007-1323.2001.02054.x
  37. Suou T, Interferon alpha inhibits intrahepatic recurrence in hepatocellular carcinoma with chronic hepatitis C: a pilot study, 10.1016/s1386-6346(00)00148-0
  38. Muto Yasutoshi, Moriwaki Hisataka, Saito Akiko, Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma, 10.1056/nejm199904013401315
  39. Nakaji M., IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat, 10.1093/carcin/bgh028
  40. Sakakima Yoshikazu, Hayakawa Akemi, Nagasaka Tetsuro, Nakao Akimasa, Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: In vitro and in vivo experiments, 10.1016/j.jhep.2007.01.030
  41. Pitot H., Altered Hepatic Foci: Their Role In Murine Hepatocarcinogenesis, 10.1146/annurev.pharmtox.30.1.465
  42. Dragan Y.P., Campbell H.A., Baker K., Vaughan J., Mass M., Pilot H.C., Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats, 10.1093/carcin/15.11.2587
  43. Tatematsu Masae, Aoki Toyohiko, Kagawa Masataka, Mera Yukinori, Ito Nobuyuki, Reciprocal relationship between development of glutathione S-transferase positive liver foci and proliferation of surrounding hepatocytes in rats, 10.1093/carcin/9.2.221
  44. Verna L, 2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation, 10.1016/0163-7258(96)00063-0
  45. Rasmussen Eva, Eriksson Barbro, Öberg Kjell, Bondesson Ulf, Rane Anders, Selective effects of somatostatin analogs on human drug-metabolizing enzymes*, 10.1016/s0009-9236(98)90148-5
  46. Blanck Agneta, Hansson Tiiu, Eriksson Lennart C., Gustafsson Jan-Åke, Growth hormone modifies the growth rate of enzyme-altered hepatic foci in male rats treated according to the resistant hepatocyte model, 10.1093/carcin/8.11.1585
  47. Pagès Philippe, Benali Naoual, Saint-Laurent Nathalie, Estève Jean-Pierre, Schally Andrew V., Tkaczuk Jean, Vaysse Nicole, Susini Christiane, Buscail Louis, sst2 Somatostatin Receptor Mediates Cell Cycle Arrest and Induction of p27Kip1 : EVIDENCE FOR THE ROLE OF SHP-1, 10.1074/jbc.274.21.15186
  48. Kwon Young Hye, Jovanovic Aleksandra, Serfas Michael S., Kiyokawa Hiroaki, Tyner Angela L., p21 Functions to Maintain Quiescence of p27-deficient Hepatocytes, 10.1074/jbc.m203388200
  49. Lennartsson P, Wild-type p53 expression in liver tissue and in enzyme-altered foci: an in vivo investigation on diethylnitrosamine-treated rats, 10.1093/carcin/19.7.1231
  50. Hsu Shih-Lan, Chen Mei-Chih, Chou Ya-Hui, Hwang Guang-Yuh, Yin Sui-Chu, Induction of p21CIP1/Waf1and Activation of p34cdc2Involved in Retinoic Acid-Induced Apoptosis in Human Hepatoma Hep3B Cells, 10.1006/excr.1999.4397